Skip to main content

Table 1 Prospective studies assessing complication rates in untreated distal deep vein thrombosis (DVT) patients

From: The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial

Author/year

Population

Sample size

Diagnostic method

Duration of follow-up for primary endpoint

VTE complication

rate

Schwarz et al. 2010 [22]

Low-risk ambulatory patients with isolated calf muscle thrombus

53

CUS

3 months

2/53 = 3.77%

Palareti et al. 2010 [21]

Symptomatic outpatients

65

CUS

3 months

5/64 = 7.8%

Macdonald et al. 2003 [19]

Mostly symptomatic surgical and medical inpatients (68.6%) with isolated calf muscle vein thrombus

135

CUS

3 months

4/135 = 3%

Schwarz et al. 2001 [23]

Symptomatic outpatients with isolated calf muscle vein thrombosis

32

CUS

3 months

8/32 = 25%

Lohr et al. 1995 [18]

Mostly symptomatic surgical and medical inpatients (59.4%)

192

CUS

4 weeks

21/169 = 12.4%

Oishi et al. 1994 [20]

Asymptomatic postoperative total hip replacement/total knee replacement patients

41

CUS

12 months

7/41 = 17.1%

Lagerstedt et al. 1985 [17]

Symptomatic medical patients

28

Isotopic uptake confirmed by ascending phlebography

90 days

8/28 = 29%

  1. CUS = compression ultrasound; VTE = venous thromboembolic complication rate: this refers to ascending proximal extension of the thrombus to the popliteal vein or development of symptomatic pulmonary embolism, except for the study by Schwarz et al. [23]. In this trial, patients were commenced on therapeutic anticoagulation if the distal thrombus propagated to any of the deep calf veins. Many cases were therefore treated prior to potential popliteal extension.